Articles

Showing 25 articles

• Systematic Review

  Published 12 October 2026

  Chinese medicine combined with EGFR-TKIs in EGFR-mutated advanced NSCLC: a meta-analysis of efficacy and safety

  Xiaohong Li · Die Qian · Shuai Liu · Mingmin Na · Bihong Dai · Chunping Wan

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1942222

• Review

  Published 12 October 2026

  Flavonoids in cancer pharmacology: molecular mechanisms, tumor microenvironment regulation, and drug resistance

  Zhengyuan Yu · Zhanyi Zhou · Ni Yin · Hongcheng Ge

  Frontiers in Pharmacology

  doi 10.3389/fphar.2026.1969337

• Original Research

  Published 12 October 2026

  Metformin and atorvastatin ameliorate MASH via the AMPK/NF-κB pathway

  Bin Zhang · Na Li · Fang Liu · Guorui Wang · Quanwei Chen · Yiming Sun · Ni Yang · Hao Zhang · Jianjun Han

  Frontiers in Endocrinology

  doi 10.3389/fendo.2026.1972846

• Case Report

  Published 9 October 2026

  Durable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case report

  Po Lin Ooi · Jamin Munchar Elias · Francis Yew Fu Tieng

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1964934

• Review

  Published 9 October 2026

  Progress on therapeutic mRNA vaccines for cancer

  Siyu Wu · Huarong Liao · Wei Zhang

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1980190

• Original Research

  Published 9 October 2026

  Adverse reactions of immune checkpoint inhibitors combined with acetaminophen/non-steroidal anti-inflammatory drugs (NSAIDs): a pharmacovigilance analysis of drug–drug interactions

  Xiayang Ren · Lihui Xue · Yanfeng Wang · Jian Xiao

  Frontiers in Pharmacology

  doi 10.3389/fphar.2026.1833275

• Original Research

  Published 1 October 2026

  Exploring the immune enhancement effect of radiotherapy combined with NK cells on non-small cell lung cancer based on proteomics technology

  Cui Chang · Tang Youming · Lu Ying · Lei Ningning · Guo Chunhui · Wei Dekai · Liang Mei · Wu Qiyuan · Liu Gechen · Wu Fasheng · Chen Jibing

  Oncology Reviews

  doi 10.3389/or.2026.1853377

• Original Research

  Published 30 September 2026

  Yaobitong plus celecoxib for low back pain: a Chinese multicenter cohort and network pharmacology study

  Huahui Gong · Chenxing Lu · Zhanghao Guo · Min Wu · Di Wu · Xu Zheng · Lei Liu · Fenghua Chen · Changyou Li

  Frontiers in Pain Research

  doi 10.3389/fpain.2026.1915365

• Original Research

  Published 25 September 2026

  Association of a stellate ganglion block-based care pathway with hypnotic medication reduction in chronic insomnia with anxiety symptoms: a real-world retrospective cohort study

  Dongze Wang · Xiaohan Wang · Wenyuan Wang · Yanyong Wang

  Frontiers in Sleep

  doi 10.3389/frsle.2026.1923070

• Review

  Published 25 September 2026

  CLDN18 and FGFR2 splicing variants are emerging tumor-associated antigens for cancer therapy

  Masuko Katoh · Masaru Katoh

  Frontiers in Molecular Medicine

  doi 10.3389/fmmed.2026.1927389

• Review

  Published 17 September 2026

  Next-generation nanomedicine for cancer therapy: advances, challenges, and future perspectives

  Biswajit Mohanty · Puja Saikia · Piyush Pandey · Chira R. Bhattacharjee

  Frontiers in Chemistry

  doi 10.3389/fchem.2026.1920337

• Original Research

  Published 8 September 2026

  Bidirectional network hubs: NT-genes as candidate targets for partial cancer reversal

  Gabriel Gil · Rolando Perez · Augusto Gonzalez

  Frontiers in Systems Biology

  doi 10.3389/fsysb.2026.1868020

• Perspective

  Published 21 August 2026

  Holding the line against artemisinin partial resistance in Africa: the case for preemptive treatment policy

  Shyamkumar Sriram

  Frontiers in Malaria

  doi 10.3389/fmala.2026.1916099

• Original Research

  Published 7 August 2026

  Exploring the genomic landscape of antimicrobial resistance in XDR-ESKAPE pathogens: evidence-based implications for organism-targeted therapy in sepsis

  Parkhi Shrivastava · Puneet Gandhi · Lalit Kumar · Anurag Yadava

  Frontiers in Disaster and Emergency Medicine

  doi 10.3389/femer.2026.1884260

• Original Research

  Published 6 August 2026

  Adjunctive antimycobacterial and immunomodulatory effects of Allium cepa (pink variety) in a rabbit model of latent-like mycobacterial infection

  Theophilus Kwesi Ninkyi · Eric Ogyam · Kelvin Atta Agyapong · Cynthia Amaning Danquah

  Frontiers in Tuberculosis

  doi 10.3389/ftubr.2026.1874315

• Systematic Review

  Published 20 July 2026

  Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study

  Shashank Joshi · Shambo Samrat Samajdar · Arvind Gupta · Mithun Bhartia · Sailesh Lodha · Supratik Bhattacharyya · Krishna Seshadri · Lakshmi Nagendra · A. G. Unnikrishnan · Dakshata Padhye · Lakshmi Nalini Kopalle · Ashok Kumar Das · Om Lakhani · Jothydev Kesavadev · Ameya Joshi · Sambit Das · Smriti Gadia · Thamburaj Anthuvan

  Frontiers in Clinical Diabetes and Healthcare

  doi 10.3389/fcdhc.2026.1733995

• Case Report

  Published 15 July 2026

  Case Report: Early-onset psychosis as a sentinel manifestation of 3q29 deletion syndrome in an adolescent with neurodevelopmental disorders

  W. Vidal · B. Masotto · M. Viñas-Jornet · J. A. Ramos-Quiroga · G. Español-Martín

  Frontiers in Child and Adolescent Psychiatry

  doi 10.3389/frcha.2026.1823061

• Case Report

  Published 15 July 2026

  Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer

  Hang Yin · Xiaomeng Zhang · Bing Song · Hui Li · Kun Liu · Chengzheng Zhang

  Frontiers in Radiology

  doi 10.3389/fradi.2026.1800543

• Mini Review

  Published 15 June 2026

  Distribution of nanotechnology in the cancer therapeutics market as a multimodal treatment: comparison with predecessors and emergence in the commercial field

  Ishita Chanana · Jagdish Verma · Aparajita Sharma · Nitesh Priyadarshi

  Frontiers in Nanotechnology

  doi 10.3389/fnano.2026.1796622

• Systematic Review

  Published 5 June 2026

  Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

  Abdullah Alabbasi · Muhanad Alzahrani · Ziyad Alzahrani · Faris Sultan · Maha AlQahtani · Alaa Sultan

  Oncology Reviews

  doi 10.3389/or.2026.1745071

• Original Research

  Published 28 April 2026

  Sacubitril valsartan combined with bisoprolol reduces doxorubicin-induced cardiotoxicity in rats by attenuating oxidative stress

  Ping Liu · Hui Yang · Runqi Li · Hui Huang · Min Xu

  Experimental Biology and Medicine

  doi 10.3389/ebm.2026.10946

• Original Research

  Published 8 April 2026

  Synergistic efficacy of combined neurolysis and methylcobalamin in peripheral nerve injury: a randomized clinical trial

  Xuwei Hu · Zuoshi Li

  Frontiers in Integrative Neuroscience

  doi 10.3389/fnint.2026.1747898

• Review

  Published 31 March 2026

  Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms

  Gökhan Mergen · Hans C. Hasselbalch

  Frontiers in Hematology

  doi 10.3389/frhem.2026.1749376

• Brief Research Report

  Published 5 January 2026

  Dual RNA polymerase I inhibition with CX-5461 and BMH-21 synergizes in breast cancer by activating p53-dependent stress

  Jonathan Y. Chung · Kristen N. Nguyen · Bruce A. Knutson

  Frontiers in Drug Discovery

  doi 10.3389/fddsv.2025.1677461

• Drug Delivery

  Published 16 September 2024

  Electrospun patches to deliver combination drug therapy for fungal infections

  Karolina Dziemidowicz · Mark Meszarik · Jacopo Piovesan · Mazna A. Almatroudi · Gareth R. Williams · Sudaxshina Murdan

  Frontiers in Drug Delivery

  doi 10.3389/fddev.2024.1458009